Shopping Cart
Remove All
Your shopping cart is currently empty
KB-74935
Copy Product Info
😃Good
Catalog No. T32368Cas No. 946398-78-3
Alias KB 74935
KB-74935 is an enzyme inhibitor and a mineralocorticoid receptor antagonist used to treat cholesterol, hypolipidemia, neurological disorders, and Alzheimer's disease.
KB-74935
Copy Product Info😃Good
Purity: 99.4%
Catalog No. T32368Alias KB 74935Cas No. 946398-78-3
KB-74935 is an enzyme inhibitor and a mineralocorticoid receptor antagonist used to treat cholesterol, hypolipidemia, neurological disorders, and Alzheimer's disease.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $256 | In Stock | In Stock | |
| 5 mg | $525 | In Stock | In Stock | |
| 10 mg | $659 | In Stock | In Stock | |
| 25 mg | $783 | In Stock | In Stock | |
| 50 mg | $903 | In Stock | In Stock | |
| 100 mg | $1,050 | In Stock | In Stock | |
| 200 mg | $1,230 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:99.4%
Appearance:Solid
Color:White
Contact us for more batch information
Product Introduction
KB-74935 AI Summary
KB-74935 exhibits potent inhibition of human and mouse 11betaHSD1 enzyme with an IC50 value of 10.0 nM. It has good metabolic stability in both mouse and human liver microsomes, with a half-life of more than 0.5 hours. In vivo studies in mice show significant inhibition of 11betaHSD1 in epididymal fat tissue and liver, with inhibition percentages of 80.0% and 95.0% respectively. The compound displays favorable pharmacokinetic profiles in mice, including a Tmax of 4.0 hours, Cmax of 2996.58 nM, clearance of 5.0 mL/min/kg, volume of distribution at steady state (Vdss) of 2.6 L/kg, and half-lives ranging from 7.2 to 7.3 hours. Its oral bioavailability in mice is 50.0% at a dose of 10 mg/kg. Drug uptake measurements indicate tissue-specific distribution and accumulation in mouse serum, liver, and fat tissues. Additionally, KB-74935 shows variable intrinsic clearance rates in human liver microsomes (ranging from less than 3 to greater than 150 µL/min/mg) and a clearance rate of 63.1 µL/min per 10^6 cells in rat hepatocytes, suggesting metabolic activities in both human and rat liver cells..
Note: Summary generated by AI. Data source: ChEMBL 
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | KB-74935 is an enzyme inhibitor and a mineralocorticoid receptor antagonist used to treat cholesterol, hypolipidemia, neurological disorders, and Alzheimer's disease. |
| Synonyms | KB 74935 |
| Molecular Weight | 479.88 |
| Formula | C19H18ClF4N3O3S |
| Cas No. | 946398-78-3 |
| Smiles | C(F)(F)(F)C1=C(C=CC(F)=C1)N2C[C@@H](C)N(S(=O)(=O)C3=C(Cl)C=C(C(N)=O)C=C3)CC2 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| Solubility Information | DMSO: 4.8 mg/mL (10 mM), Sonication is recommended.  | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy KB-74935 | purchase KB-74935 | KB-74935 cost | order KB-74935 | KB-74935 chemical structure | KB-74935 formula | KB-74935 molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.